Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.35 |
| ▸ | CPA1 | P15085 | 5/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | HBB | P68871 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.30 |
| ▸ | F2 | P00734 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9683817 | 0.83 | CPA1 (0.34) | ALDH1A1HIF1AHPGDCPA1TP53 | |
| SCHEMBL10462856 | 0.79 | CPA1 (0.32) | ALDH1A1CPA1MEN1KMT2AMAPT | |
| SCHEMBL19283841 | 0.77 | ALDH1A1 (0.39) | ALDH1A1HIF1ACPA1LMNAMEN1 | |
| SCHEMBL27853893 | 0.77 | ALDH1A1 (0.37) | ALDH1A1CPA1KMT2AKDM4ETDP1 | |
| SCHEMBL27876382 | 0.74 | CPA1 (0.37) | ALDH1A1CPA1LMNAMEN1KMT2A | |
| SCHEMBL19283824 | 0.74 | CPA1 (0.41) | ALDH1A1CPA1KMT2AKDM4ETDP1 | |
| SCHEMBL9243465 | 0.73 | ALDH1A1 (0.37) | ALDH1A1HIF1AHPGDCA5ACA5B | |
| SCHEMBL5404644 | 0.71 | ALDH1A1 (0.38) | ALDH1A1HIF1AHPGDCA5ACA5B | |
| SCHEMBL18081010 | 0.71 | ALDH1A1 (0.35) | ALDH1A1HIF1AHPGDCA5ACA5B | |
| SCHEMBL30956504 | 0.71 | ALDH1A1 (0.35) | ALDH1A1HIF1AHPGDCA5ACA5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114477481-A | Degradable scale and corrosion inhibitor for phosphorus-containing reclaimed water and preparation method thereof | 河北省科学院能源研究所 | 2022-05-13 | — | — | CN | claimed |
| CN-105884694-A | Preparing method for ticagrelor intermediate 4,6-dichloro-2-tri-sulfydryl-5-aminopyrimidine | 上海复星医药产业发展有限公司 | 2016-08-24 | — | — | CN | claimed |
| CN-100456398-C | Electrolyte for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORP (JP) | 2009-01-28 | — | — | CN | claimed |
| CN-1529892-A | Electrolyte for driving electrolytic capacitor and electrolytic capacitor | 如碧空株式会社 | 2004-09-15 | — | — | CN | claimed |
| US-20240140933-A1 | OXOINDOLINE COMPOUND FOR THE TREATMENT OF INFLAMMATORY DISEASES OR CANCER | HOFFMANN-LA ROCHE INC. (US) | 2024-05-02 | — | — | US | disclosed |
| EP-4341252-A1 | OXOINDOLINE COMPOUND FOR THE TREATMENT OF INFLAMMATORY DISEASES OR CANCER | F. Hoffmann-La Roche AG (CH) | 2024-03-27 | — | — | EP | disclosed |
| CN-117088818-A | Synthesis method of 4, 6-dichloro-2-propylthio-5-aminopyrimidine | 河北博伦特药业有限公司 | 2023-11-21 | — | — | CN | disclosed |
| US-20230130031-A1 | Thermoplastic Polyurethane Compositions Comprising Nitro-Substituted Polyester Diols | NOVOLOOP INC (US) | 2023-04-27 | — | — | US | disclosed |
| CN-115843302-A | Thermoplastic polyurethane compositions comprising nitro-substituted polyester diols | 诺弗洛普有限公司 | 2023-03-24 | — | — | CN | disclosed |
| CN-115843300-A | Polymerizable compositions comprising nitro-substituted polyester diols | 诺弗洛普有限公司 | 2023-03-24 | — | — | CN | disclosed |
| EP-4118131-A1 | THERMOPLASTIC POLYURETHANE COMPOSITIONS COMPRISING NITRO-SUBSTITUTED POLYESTER DIOLS | Novoloop, Inc. (US) | 2023-01-18 | — | — | EP | disclosed |
| EP-4118126-A1 | POLYMERIZABLE COMPOSITIONS COMPRISING NITRO-SUBSTITUTED POLYESTER DIOLS | Novoloop, Inc. (US) | 2023-01-18 | — | — | EP | disclosed |
| CN-105645604-A | Low-phosphorus scale and corrosion inhibitor | 潘福昆 | 2016-06-08 | — | — | CN | disclosed |
| CN-100456398-C | Electrolyte for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORP (JP) | 2009-01-28 | — | — | CN | disclosed |
| CN-1529892-A | Electrolyte for driving electrolytic capacitor and electrolytic capacitor | 如碧空株式会社 | 2004-09-15 | — | — | CN | disclosed |
| EP-0354778-B1 | Method for production of dimeric alkaloids | MITSUI PETROCHEMICAL IND (JP) | 1994-03-16 | — | — | EP | disclosed |
| US-5037977-A | Method for production of dimeric alkaloids | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1991-08-06 | — | — | US | disclosed |
| EP-0354778-A2 | Method for production of dimeric alkaloids | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1990-02-14 | — | — | EP | disclosed |
| US-4503222-A | INSECTICIDES | SHELL OIL COMPANY (US) | 1985-03-05 | — | — | US | disclosed |
| EP-0114705-A1 | Pesticidal nitromethane derivatives | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1984-08-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240140933-A1 | OXOINDOLINE COMPOUND FOR THE TREATMENT OF INFLAMMATORY DISEASES OR CANCER | IL1B, IL1A, IL1R1 | ALDH1A1 302/4885HIF1A 1103/4885HPGD 893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.